Actively Recruiting
Early Thrombolysis Guided by AI-Assisted App in Patients With STEMI
Led by Shenyang Northern Hospital · Updated on 2025-09-18
3356
Participants Needed
1
Research Sites
203 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The aim of the study is to elucidate whether guiding by a novel artificial intelligence assisted mobile application can improve the clinical outcomes of patients in whom "guide wire passing through the lesion" could not be achieved within 120 min after diagnosis of STEMI, compared to conventional treatment strategies. With concerns of the inadequate use of thrombolysis in patients with STEMI in China, this study applies a new artificial intelligence assisted mobile application to guide the process of thrombolysis combined with PCI treatment, in order to accomplish the rapid coordination and cooperation of the whole medical network during re-perfusion treatment in different regions and different medical institutions in China, increases the proportion of early thrombolysis in pre-hospital setting, shortens the time from STEMI onset to reperfusion, and provides a reliable, effective and replicable new strategy for promoting and optimizing early reperfusion.
CONDITIONS
Official Title
Early Thrombolysis Guided by AI-Assisted App in Patients With STEMI
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age between 18 and 80 years
- Chest pain lasting more than 30 minutes with onset within 12 hours
- ECG showing ST segment elevation after J-point in 2 or more adjacent leads (limb leads ≥ 0.1 mv or chest leads ≥ 0.2 mv)
- Expected that "guide wire passing through the lesion" cannot be achieved within 120 minutes after STEMI diagnosis
- Signed informed consent
You will not qualify if you...
- Cardiac rupture
- Complete left bundle branch block (LBBB) or ventricular pacing
- Contraindications to thrombolysis
- Serious comorbidities
- Complex heart disease
- Conditions unsuitable for clinical trials
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
No. 83, Wenhua Road, Shenhe District, Shenyang City
Shenyang, Liaoning, China
Actively Recruiting
Research Team
K
Kai Xu, MD,PhD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here